As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.
Anxiety, a pervasive mental state, involves excessive worry, fear, and apprehension about future events. It manifests physically and emotionally, often leading to restlessness, difficulty concentrating, and heightened arousal. Treatment may involve therapy, medication, or coping strategies to manage symptoms and improve daily functioning.
E8 Dr. Richard Baron discusses the challenges facing primary care, emphasizing the need for well-resourced, team-based approaches. He highlights the importance of increasing investment in primary care to improve patient outcomes and reduce costs. Baron also supports focusing on Long COVID as a critical issue for future healthcare policy discussions.
E6 Todd Davenport discusses the overlap between Long COVID and ME/CFS, emphasizing differing pathogens, bioenergetic dysfunction, and diagnostic challenges, while advocating for patient history, symptom validation, and pacing strategies for management.
This research conducted interviews via telemedicine of 165 patients with Long COVID over a 2-year time frame.
Researchers are looking at whether medications used to treat or prevent HIV may also alleviate long Covid symptoms.
Chimére L Sweeney emphasizes the need for awareness, stating, "I want to help Black people tell their stories of long covid." The discussion highlights the importance of empathy and support for those affected, advocating for better healthcare access and understanding.
Danielle Beckham Neuroscientist at the @CNPRCresearch . MS in Biophysics, PhD in Biological Chemistry. With her latest entry to NeuroArt "Unwelcome guest: SARS-Cov-2" - If you like it, please vote!
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t